DEBBIE FROGOZO: Open Payments
NPI 1982814638 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,092 in 51 payments from 18 companies in 2025. Trend: 2023 $823 · 2024 $607 · 2025 $1,092
Food & beverage: $1,092
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $184 |
| SANOFI PASTEUR INC. | 6 | $130 |
| ABBVIE INC. | 4 | $101 |
| Novo Nordisk Inc | 5 | $91 |
| GlaxoSmithKline, LLC. | 4 | $88 |
| Lilly USA, LLC | 4 | $81 |
| Astellas Pharma US Inc | 3 | $73 |
| ABIOMED | 3 | $63 |
| Boston Scientific Corporation | 1 | $56 |
| SANOFI-AVENTIS U.S. LLC | 2 | $45 |
Products named: NURTEC ODT, Veozah, BEYFORTUS, MOUNJARO, Wegovy, WaveWriter Alpha Prime 16, TZIELD, PREVNAR 20.
Industry payments across CA — which companies pay providers there.
